➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
McKinsey
Dow
Johnson and Johnson
Moodys

Last Updated: September 21, 2021

DrugPatentWatch Database Preview

Formulation information for generic ingredient: RIFAPENTINE


Email this page to a colleague

« Back to Dashboard

Bedaquiline

CASRN: 843663-66-1

Manufacturing Methods

<truncated in preview>

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Colorcon
Baxter
AstraZeneca
Moodys